ABXL
ABXLNYSENONENONE
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$25.68
52W Low
$18.62
50-Day MA
$25.64
200-Day MA
$25.51
Dividend Yield
9.47%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ABXL
Abraxas BioScience (ABXL) is a biopharmaceutical company at the forefront of developing innovative therapies for serious medical conditions, particularly in areas marked by significant unmet medical needs. With a strong pipeline of proprietary drug candidates, ABXL leverages advanced technologies in drug discovery to create solutions that promise meaningful advancements in patient care. The company is dedicated to scientific rigor and regulatory compliance, actively collaborating with academic institutions and industry partners to enhance its research capabilities and drive the delivery of transformative healthcare solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
3.59%
HV 20-Day
3.51%
HV 30-Day
4.23%
HV 60-Day
6.27%
HV Rank
18.7%
Volatility is currently contracting
More NONE Stocks
SOJESouthern Company (The) Series 2DTGDTE Energy Company 2021 Series EDTBDTE Energy Company 2020 SeriesCGABLThe Carlyle Group Inc. 4.625% Subordinated Notes due 2061MGRBAffiliated Managers Group, Inc.UZFArray Digital Infrastructure, IUZDArray Digital Infrastructure, INIQNIQ Global Intelligence plcRILYTB. Riley Financial Inc. 6.00% Senior Notes Due 2028HWCPZHancock Whitney Corporation - 6OXLCLOxford Lane Capital Corp. 6.75% Notes due 2031BBBYBed Bath & Beyond, Inc.
Data last updated: 5/25/2026